Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
WellDoc FDA clearance
Welldoc's Bluestar lands FDA clearance for expanded insulin dosing support
By
Emily Olsen
|
02:35 pm |
September 22, 2021
The new clearance expands its insulin dosing support to bolus and premixed insulin titration for Type 2 diabetes.